Financhill
Back

Tonix Pharmaceuticals Holding Corp. 10K Form

Sell
50

TNXP
Tonix Pharmaceuticals Holding Corp.

Last Price:
$19.52
Seasonality Move:
1.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive TNXP News And Ratings

See the #1 stock for the next 7 days that we like better than TNXP

TNXP Financial Statistics

Sales & Book Value

Annual Sales: $10.1M
Cash Flow: $-31.5M
Price / Cash Flow: 0
Annual Sales: $22.73
Price / Book: 0.57

Profitability

EPS (TTM): -986.98720
Net Income (TTM): $-99.2M
Gross Margin: $-1.1M
Return on Equity: -62.54%
Return on Assets: -55.71%

Key Tonix Pharmaceuticals Holding Corp. Financial Ratios

  • The Gross Profit Margin over the past 18 years for TNXP is -10.82%.
  • The Selling, General & Administrative Expenses for TNXP have been equal to 397.28% of Gross Profit Margin.
  • The Research & Development expenses have been 396.00% of Revenue.
  • The Net Earning history of TNXP is -1,288.25% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 11 years.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TNXP
CUSIP: 890260
Website: tonixpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.89
Quick Ratio: 9.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TNXP Technical Analysis vs Fundamental Analysis

Sell
50
Tonix Pharmaceuticals Holding Corp. (TNXP) is a Sell

Is Tonix Pharmaceuticals Holding Corp. a Buy or a Sell?